Accumulating evidence suggests that a reduced level of CRT is associated with the pathologies of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS)23,31 and Alzheimer’s disease (AD)22,32. This evidence concerns the gene CALR and neurodegenerative disease.